UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

The Lancet (British edition), 2013-02, Vol.381 (9865), p.468-475

2013

Link zum Volltext

Verfügbarkeit prüfen

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

Journal of hepatology, 2015-03, Vol.62 (3), p.533-540

2015

Link zum Volltext

Verfügbarkeit prüfen

Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients

PloS one, 2014-03, Vol.9 (3), p.e92717

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B

Cancer, 2015-10, Vol.121 (20), p.3631-3638

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.1240-1248

2014

Link zum Volltext

Verfügbarkeit prüfen

Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies

Journal of hepatology, 2024-06, Vol.80 (6), p.882-891

2024

Link zum Volltext

Verfügbarkeit prüfen

Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2014-04, Vol.146 (4), p.980-988.e1

2014

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

The lancet. Gastroenterology & hepatology, 2016-11, Vol.1 (3), p.185-195

2016

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

The lancet. Gastroenterology & hepatology, 2016-11, Vol.1 (3), p.196-206

2016

Link zum Volltext

Verfügbarkeit prüfen

Intracellular Nucleotide Levels during Coadministration of Tenofovir Disoproxil Fumarate and Didanosine in HIV-1-Infected Patients

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1549-1555

2011

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

Journal of hepatology, 2014-12, Vol.61 (6), p.1228-1237

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment

Clinical pharmacokinetics, 2006-01, Vol.45 (11), p.1115-1124

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

Hepatology (Baltimore, Md.), 2013-08, Vol.58 (2), p.505-513

2013

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study

Journal of hepatology, 2017-01, Vol.66 (1), p.11-18

2017

Link zum Volltext

Verfügbarkeit prüfen

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks

Alimentary pharmacology & therapeutics, 2024-01, Vol.59 (2), p.217-229

2024

Link zum Volltext

Verfügbarkeit prüfen

Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients

Journal of acquired immune deficiency syndromes (1999), 2009-06, Vol.51 (2), p.163

2009

Link zum Volltext

Verfügbarkeit prüfen

Histologic Evidence of Active Liver Injury in Chronic Hepatitis B Patients With Normal Range or Minimally Elevated Alanine Aminotransferase Levels

Journal of clinical gastroenterology, 2010-08, Vol.44 (7), p.510-516

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of Tenofovir Disoproxil Fumarate on the Pharmacokinetics and Pharmacodynamics of Total, R-, and S-Methadone

Pharmacotherapy, 2004-08, Vol.24 (8), p.970-977

2004

Link zum Volltext

Verfügbarkeit prüfen

Cross-Reactivity in HIV-infected Patients Switched from Trimethoprim-Sulfamethoxazole to Dapsone

Pharmacotherapy, 1998-07, Vol.18 (4), p.831-835

1998

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of esmolol and ASL-8123 in renal failure

Clinical pharmacology and therapeutics, 1989-03, Vol.45 (3), p.321-327

1989

Link zum Volltext

Verfügbarkeit prüfen

Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure

Clinical pharmacology and therapeutics, 1989-05, Vol.45 (5), p.527-534

1989

Link zum Volltext

Verfügbarkeit prüfen

Grepafloxacin Pharmacokinetics in Individuals with Hepatic Dysfunction

Clinical pharmacokinetics, 1997, Vol.33 Suppl 1 (Supplement 1), p.25-31, Article 25

1997

Link zum Volltext

Verfügbarkeit prüfen

Use of intrathecally administered morphine in the treatment of postoperative pain after lumbar spinal surgery: a prospective, double-blind, placebo-controlled study

Neurosurgery, 1991-05, Vol.28 (5), p.700-704

1991

Link zum Volltext

Verfügbarkeit prüfen

Roxithromycin disposition in patients on continuous ambulatory peritoneal dialysis

Journal of antimicrobial chemotherapy, 1995-07, Vol.36 (1), p.157-163

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(62)
Male
(59)
Science & Technology
(59)
Life Sciences & Biomedicine
(58)
Female
(57)
Adult
(49)
Aged
(32)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Young Adult
(18)
Oncology
(17)
Aged, 80 And Over
(16)
Adenine - Analogs & Derivatives
(13)
Treatment Outcome
(13)
Double-Blind Method
(12)
Gastroenterology & Hepatology
(12)
Hepatitis B, Chronic - Drug Therapy
(11)
Adenine - Therapeutic Use
(10)
Antiviral Agents - Therapeutic Use
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B

Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA

Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies

Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Intracellular Nucleotide Levels during Coadministration of Tenofovir Disoproxil Fumarate and Didanosine in HIV-1-Infected Patients

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks

Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients

Histologic Evidence of Active Liver Injury in Chronic Hepatitis B Patients With Normal Range or Minimally Elevated Alanine Aminotransferase Levels

Effect of Tenofovir Disoproxil Fumarate on the Pharmacokinetics and Pharmacodynamics of Total, R-, and S-Methadone

Cross-Reactivity in HIV-infected Patients Switched from Trimethoprim-Sulfamethoxazole to Dapsone

Pharmacokinetics of esmolol and ASL-8123 in renal failure

Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure

Grepafloxacin Pharmacokinetics in Individuals with Hepatic Dysfunction

Use of intrathecally administered morphine in the treatment of postoperative pain after lumbar spinal surgery: a prospective, double-blind, placebo-controlled study

Roxithromycin disposition in patients on continuous ambulatory peritoneal dialysis

Aktive Filter

Suchergebnisse filtern